Jin Fu Kang Oral Liquid(金复康口服液),made of traditional Chinese drugs for supplementing qiand nourishing yin,was developed according to the common symptoms in lung carcinoma withdeficiency of both qi and yin.Of the 96 cases in the Jin Fu Kang group,1 case got complete remission(CR)after treatment,8 cases partial remission(PR),52 cases no change(NC),PR+NC covering63.5%.Of the 52 cases in the group of Jin Fu Kang plus chemotherapy,11 cases got PR aftertreatment,26 cases NC,PR+NC covering 71.2%.Of the 25 cases in the chemotherapy group,4 casesgot PR after treatment,11 cases NC,PR+NC covering 60.0%.The results show that the therapeuticeffectiveness in the Jin Fu Kang group and the group of Jin Fu Kang plus chemotherapy was betterthan that in the chemotherapy group.The one-year survival rate and the two-year survival rate aftertreatment in the Jin Fu Kang group were 67.3% and 67.3% respectively;66.7% and 66.7% in thegroup of Jin Fu Kang plus chemotherapy;and 40.3% and 0.0% in the chemotherapy group.Theimprovement of clinical symptoms,increase of body weight and improvement of health situation(KPSmarks)after treatment in both the Jin Fu Kang group and the group of Jin Fu Kang pluschemotherapy were better than that in the chemotherapy group.Some indicators of immunology andhemogram after treatment were greatly improved in the Jin Fu Kang group,worse in thechemotherapy group,but no obvious improvement in the group of Jin Fu Kang plus chemotherapy. Jin Fu Kang Oral Liquid,made of traditional Chinese drugs for supplementing qiand nourishing yin,was developed according to the common symptoms in lung cancer withdeficiency of both qi and yin.Of the 96 cases in the Jin Fu Kang group, 1 case got complete remission(CR)after treatment,8 cases partial remission(PR),52 cases no change(NC),PR+NC covering63.5%.Of the 52 cases in the group of Jin Fu Kang plus chemotherapy,11 Cases got PR aftertreatment,26 cases NC,PR+NC covering 71.2%.Of the 25 cases in the chemotherapy group,4 casesgot PR after treatment,11 cases NC,PR+NC covering 60.0%.The results show that the therapeutic effectiveness in the The Jin Fu Kang group and the group of Jin Fu Kang plus chemotherapy was betterthan that in the chemotherapy group. The one-year survival rate and the two-year survival rate aftertreatment in the Jin Fu Kang group were 67.3% and 67.3% respectively; 66.7 % and 66.7% in thegroup of Jin Fu Kang plus chemotherapy;and 40.3% and 0.0% in the ch Emotherapy group.The improvement of clinical symptoms,increase of body weight and improvement of health situation(KPSmarks)after treatment in both the Jin Fu Kang group and the group of Jin Fu Kang plus chemotherapys better than that in the chemotherapy group.Some indicators of immunology Andhemogram after treatment were greatly improved in the Jin Fu Kang group,worse in thechemotherapy group,but no obvious improvement in the group of Jin Fu Kang plus chemotherapy.